- Stocks
- Pages
- Blogs
- Research Reports
sink_data

View

app landing page

View

bse

View

nse

View

Holiday

View

blog author

View

Author

View

Research Baskets

View

high stocks test page

View

MF_API

View

What is a Demat Account? Meaning, Benefits, Types & How It Works
4 September 2026
Read Blog

What is Mutual Fund: Definition, Benefits & How to Invest in it 
3 September 2026
Read Blog

What is an IPO? Full Form, Meaning & How It Works
2 September 2026
Read Blog

Portfolio Allocation Strategy During Interest Rate Cycles
30 June 2026
Read Blog

What happens after a company gets delisted?
19 June 2026
Read Blog

FII vs DII: Key Differences Explained
16 June 2026
Read Blog

What Is REIT?
15 June 2026
Read Blog

Difference Between Bull and Bear Market
12 June 2026
Read Blog

What is IOC in Share Market?
11 June 2026
Read Blog

What Is a Short Delivery in Share Market?
10 June 2026
Read Blog

View All Blogs

Asset Management Companies – Sector Update – Fragmentation increasing in the AMC sector
18 September 2026
Read Report

Coforge (COFORGE IN) – Event Update – Accelerating AI stack to scale production – BUY
18 September 2026
Read Report

Power – Sector Update – Transmission: PWGR leads near-term execution visibility
17 September 2026
Read Report

Cyient DLM (CYIENTDL IN) – Visit Update – Focus on B2S & new-age electronics to drive growth – HOLD
17 September 2026
Read Report

The Beat – DCX Systems set for a booming upside!
02 January 2025
Read Report

Technical Newsletter: 17-Sept-2026
17 September 2026
Read Report

JSW Steel (JSTL IN) – Q3FY25 Result Update – Better quarter, but HRC situation yet to improve – HOLD
27 January 2025
Read Report

Technical Newsletter: 16-Sept-2026
16 September 2026
Read Report

ICICI Bank (ICICIBC IN) – Q3FY25 Result Update – Asset quality remains best-in-class – BUY
27 January 2025
Read Report

Consumer Durables – Sector Update – RAC leads rebound, margins remain muted
16 September 2026
Read Report

View All Reports
Login
Open Account

Aarti Pharmalabs Ltd

Q: What is the current share price of Aarti Pharmalabs Ltd?

As of 18-Sep-2026, 15:59:22 the share price for Aarti Pharmalabs Ltd. is ₹ 820.4 on the NSE (Note: Prices are dynamic and update frequently during market hours).

Small Cap | Pharmaceuticals

₹ 820.4 -6.55(-0.79%)

Last updated: 18-Sep-2026 , 15:59:22

Aarti Pharmalabs Ltd Price Today Aarti Pharmalabs Ltd share price is ₹820.4 as on 18-Sep-2026, Down 0.79% from the previous close of ₹826.95. The stock has traded between ₹845.7 and ₹812.4 today, against a 52-week range of ₹585 to ₹940.5. Over the past year the stock is Up 60.77% range. Market capitalisation stands at ₹7868.74 crore.

Performance

Low: ₹812.4 High: 845.7

Previous Close	₹ 826.95
High	₹ 845.7
Volume	1901494
52W Range	₹ 585 - ₹ 940.5

Open	₹ 827
Low	₹ 812.4
Market Cap	₹ 7868.74 Cr

Aarti Pharmalabs Ltd Technicals

Current Price

₹ 820.4 -6.55 (-0.79%)

EMASMA

20 Day	₹ 825.853
50 Day	₹ 791.476
100 Day	₹ 759.524
200 Day	₹ 745.349

20 Day	₹ 837.243
50 Day	₹ 779.074
100 Day	₹ 734.866
200 Day	₹ 725.492

Aarti Pharmalabs Ltd Fundamentals

ROCE	10.127
P/E Ratio	35.770
P/B Ratio	3.750
Industry P/E	3.750
Debt to Equity	51.202

ROE	8.889
EPS	22.950
Dividend Yield	0.430
Book Value	218.611
Face Value	5.000

Aarti Pharmalabs Ltd Financials

Particulars	Y202603	Y202503	Y202403	Y202303	Y202203
Total Revenue	1812.8749	1784.1487	1513.141	1512.5291	943.5334
Total Expenses	1575.841	1447.8077	1238.6218	1279.1735	809.8072
Profit After Tax	176.2019	257.3488	200.6454	171.7269	106.7262

Aarti Pharmalabs Ltd Shareholding Pattern

Promoter Holdings	42.857 %
FIIs	8.174 %
DIIs	6.433 %
MutualFund	0.791 %
Retail	34.390 %
Others -	7.355 %

About Aarti Pharmalabs Ltd

Aarti Pharmalabs Limited was initially incorporated as 'Aarti Organics Limited' in 2019. The name of the Company was changed to Aarti Pharmachem Limited from Aarti Organics Limited' in July, 2021 and to Aarti Pharmalabs Limited in 2022. Company is a manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine derivatives situated in India. It specialise in developing and manufacturing Highly Potent Active Pharmaceutical Ingredients (HPAPIs) critical for various therapeutic segments such as Anti-cancer, Anti-Asthma, Anti-Hypertensive etc. In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit; further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005; commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016. It expanded block for CSD, Vapi and API, Tarapur units in 2022. In 2021-22, the Pharmaceutical Division was demerged from Aarti Industries Limited into its wholly owned subsidiary, Aarti Pharmalabs Limited, via Scheme of Arrangement for Demerger, thus making it effective on October 17, 2022 and operational from July 1, 2021. Thereafter, Company commercialised Block V at Tarapur Unit 4. Again, it enhanced Xanthine capacity to 5,000 TPA in 2023. The R&D centre in Nerul, Navi Mumbai became fully operational in FY 2024. The Company commenced operations for its se ...

Similar Stocks

Ambalal Sarabhai Enterprises Ltd Pharmaceuticals	₹ 39.97 -1.31 (-3.17%)
Amrutanjan Health Care Ltd Pharmaceuticals	₹ 493.80 +2.8 (+0.57%)
Astrazeneca Pharma India Ltd Pharmaceuticals	₹ 6,751.50 +82.5 (+1.24%)
Bliss GVS Pharma Ltd Pharmaceuticals	₹ 681.85 -8.8 (-1.27%)
Abbott India Ltd Pharmaceuticals	₹ 27,270.00 +1360 (+5.25%)
Cipla Ltd Pharmaceuticals	₹ 1,394.50 +18.2 (+1.32%)

FAQs on Aarti Pharmalabs Ltd

1. Can I buy Aarti Pharmalabs Ltd from PL Capital? ›

Yes, you can invest in Aarti Pharmalabs Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Aarti Pharmalabs Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Aarti Pharmalabs Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.

2. Does Aarti Pharmalabs Ltd pay dividends? ›

Yes, Aarti Pharmalabs Ltd has a consistent history of rewarding its shareholders through dividend payouts. Dividend frequency and amounts vary depending on the company’s financial performance and board approvals. Investors holding Aarti Pharmalabs Ltd shares on the record date announced by the company are eligible to receive dividends directly into their bank accounts linked with their Demat holdings.

3. What is the current share price of Aarti Pharmalabs Ltd ? ›

As of 18-Sep-2026 , 15:59:22 the share price for Aarti Pharmalabs Ltd. is ₹ 820.4 on the NSE (Note: Prices are dynamic and update frequently during market hours).

4. What is the 52-week high and low of Aarti Pharmalabs Ltd ? ›

The 52-week high and low of Aarti Pharmalabs Ltd share price is ₹ 585 - ₹ 940.5 as of 18-Sep-2026 , 15:59:22 .

5. What is the market capitalisation of Aarti Pharmalabs Ltd? ›

Market capitalisation of Aarti Pharmalabs Ltd is ₹7868.74Cr as of 18-Sep-2026.

6. What is the current P/E ratio of Aarti Pharmalabs Ltd? ›

The P/E (price-to-earnings) ratio of Aarti Pharmalabs Ltd is 35.770.

7. What is the current P/B ratio of Aarti Pharmalabs Ltd? ›

The P/B (price-to-book) ratio of Aarti Pharmalabs Ltd is 3.750.

8. What is the shareholding pattern of Aarti Pharmalabs Ltd? ›

As of 18-Sep-2026, promoters hold 42.857%, foreign institutional investors hold 8.174%, domestic institutional investors hold 6.433%, and the public holds 34.390%.